One80 Intermediaries Launches GeneBridge Gene Therapy Reinsurance Product
The solution mitigates the financial impact of high-cost gene therapy claims.
GeneBridge is a reinsurance facility designed for blocks of business including employer stop loss programs and health plans. Programs that purchase GeneBridge are reimbursed up to a scheduled amount for the list price and administration of the FDA-approved therapies.
More than 10,000 diseases are linked to genetic disorders fueling a rapid growth in approved treatments. At an average cost per therapy of over
“With the number of gene and cell therapies expected to double over the next two years, we saw a great need to mitigate the potentially catastrophic financial impact one or more of these claims would have on programs and employer groups,” said
The program will be administered through One80’s medical stop loss practice, a full-service Managing General Underwriter.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20240701143486/en/
Media Contact:
lmilne@one80intermediaries.com
(786) 865-4614
Source:


What is long-term care insurance, and why are premiums still rising?
This Week: Job openings, Fed meeting minutes, June nonfarm payrolls report
Advisor News
- The 6X Formula for leveraging content marketing with AI
- When a home becomes difficult to insure, the plan changes
- The inheritance gap: Helping clients plan for money that hasn’t arrived
- After the midterms: Addressing your clients’ tax concerns
- Berkeley arts tax heads toward passage while public bank measure looks likely to fail
More Advisor NewsAnnuity News
- Athene CEO criticizes offshore reinsurance, risk-taking by competitors
- DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
- John Hancock launches new fixed indexed annuity suite
- Annuities to play a larger role in workplace retirement plans
- FHLBank Pittsburgh Announces Results in 2026 Board Election
More Annuity NewsHealth/Employee Benefits News
- Oscar Health Inc. (NYSE: OSCR) Draws the Stock Spotlight on Nov. 12
- Duet Raises $15M to Scale Nurse Practitioner-Owned Clinics, Filling Critical Primary Care Gap
- Sidecar Health Named a Finalist in the 2026 Fierce Innovation Awards
- Open enrollment set to begin Nov. 1
- OPINION: Imperial County’s dental care gap goes beyond insurance coverage
More Health/Employee Benefits NewsLife Insurance News
- Three lawsuits put life insurers’ cost-of-insurance practices under scrutiny
- Military Briefs: November 12-18
- Security Benefit Series B Preferred Stock Dividend Rate Resets to 10.286%
- FHLBank Pittsburgh Announces Results in 2026 Board Election
- New Jackson Study Finds the "Sandwich Generation" Squeeze Comes from More Than Two Sides and It’s Quietly Draining Retirement Savings
More Life Insurance News